protein
Isoform 1 of Gamma-adducin
Gene
ADD3
Organism
Homo sapiens(9606)
Length
674 aa
Mass
75,671 Da
Gamma-adducin (ADD3, isoform 1) is a 75.7 kDa cytoplasmic protein involved in actin filament organization and cell membrane dynamics (UniProt: Q9UEY8-2). The protein functions in regulating the barbed ends of actin filaments and plays roles in cell morphology and synaptic plasticity through interactions with the spectrin-actin cytoskeleton.
ADD3 is expressed broadly across tissues including the central nervous system, where it contributes to neuronal architecture and axonal integrity. No specific disease annotations are listed in the UniProt record; however, adducins have been implicated in various neurological contexts through their structural roles in cytoskeletal organization.
In Alzheimer's Disease, gamma-adducin is upregulated in post-mortem brain tissue from AD patients compared to age-matched controls (Chaparral AD proteomics). Across three subcellular fractions examined in human post-mortem AD brain using TMT-labeled quantitative proteomics, the mean log2 fold-change was +0.72, indicating modest but consistent elevation. This upregulation may reflect compensatory cytoskeletal remodeling or altered synaptic dynamics associated with neurodegeneration in AD.
Generated from the curated entity record below. May contain errors — verify against source links.
Proteomics Evidence · AD
↑ Up in ADP3
+0.813
P2
+0.404
S2
not detected
S3
+0.938
Mean log₂FC across detected fractions: +0.7183 (3 of 4 fractions detected)
Human post-mortem AD brain vs age-matched controls, TMT-labeled, 4 subcellular fractions (P2, P3, S2, S3), DDA proteomics.
Related Publications
Browse all →Tau molecular diversity contributes to clinical heterogeneity in Alzheimer's disease.
Dujardin Simon et al.Nature medicine2020PMID 32572268Deep Multilayer Brain Proteomics Identifies Molecular Networks in Alzheimer's Disease Progression.
Bai Bing et al.Neuron2020PMID 31926610A Multi-network Approach Identifies Protein-Specific Co-expression in Asymptomatic and Symptomatic Alzheimer's Disease.
Seyfried Nicholas T et al.Cell systems2017PMID 27989508Large-scale deep multi-layer analysis of Alzheimer's disease brain reveals strong proteomic disease-related changes not observed at the RNA level.
Johnson Erik C B et al.Nature neuroscience2022PMID 35115731Organization and regulation of gene transcription.
Cramer PatrickNature2019PMID 31462772
Sources
Last updated 5/8/2026, 6:36:49 AM
